News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
(EMAILWIRE.COM, February 05, 2009 ) New York, NY - Lawyer Central has recently updated its Gadolinium Contrast Dye Resource Center, which provides information to consumers about the risks associated with the use of gadolinium based MRI contrast dyes. Although gadolinium contrast dyes pose no serious risk for most individuals, those with kidney problems may be unable to quickly eliminate the gadolinium from their bodies following the contrast dye injection for an MRI. This prolonged exposure to gadolinium can lead to the development of a condition known as Nephrogenic Systemic Fibrosis (NSF).
Before the recent discovery of the potential side effects of gadolinium, doctors praised the element because it allowed for enhanced imaging in MRIs. Gadolinium produces a visible contrast in blood vessels, organs and tissues, which aids medical professionals in detecting tumors or abnormal tissues. In the United States, gadolinium was manufactured by GE Healthcare, Bayer HealthCare Pharmaceuticals, Tyco/Mallinckrodt and Bracco Diagnostics under the following brand names: Magnevist, MultiHance, Omniscan, OptiMARK and ProHance.
Although gadolinium has useful properties in the medical field, it also poses health risks for patients with kidney conditions. Recent studies have shown a link between gadolinium and NSF, the potentially life-threatening disease that causes fibrosis of the skin, eyes, joints and internal organs. The first diagnosis of Nephrogenic Systemic Fibrosis occurred in 1997. In serious cases, it can lead to immobility and breathing difficulties, with the potential to be fatal. This is a relatively new disease and no cure has been discovered yet. The Food and Drug Administration (FDA) issued three warnings about the effects of gadolinium between June 2006 and May 2007. In addition, several lawsuits have been filed aimed at the manufacturers of gadolinium contrast dye alleging that these manufacturers failed to warn consumers about its risks and failed to adequately test it.
To learn more about gadolinium and NSF, visit http://injury.lawyercentral.com/Gadolinium-Contrast-Dye-Lawyers-Attorneys--1-106.html. Lawyer CentralÂ’s gadolinium lawyers are offering a free case evaluation for individuals who have developed NSF as a result of gadolinium exposure. If you are interested in learning about the legal rights of individuals who have been harmed by gadolinium, fill out the form on the right side of the page. Gadolinium attorneys can advise you of your legal options and help you get the justice you deserve.
About Lawyer Central
The Lawyer Central Network is an exclusive nationwide network of attorneys highly dedicated to their unique areas of practice, including gadolinium contrast dye litigation. Lawyer Central is emerging as the leading public relations and mixed media marketing organization for fast-growing law firms and forward-thinking attorneys. Lawyer Central membership includes a variety of media exposure ranging from practice area video filming, through interviews and complete public relations and internet relations management.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:
